These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8692811)

  • 1. Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors.
    Xu RM; Carmel G; Kuret J; Cheng X
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6308-13. PubMed ID: 8692811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity.
    Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
    J Biol Chem; 1996 Oct; 271(42):26157-64. PubMed ID: 8824261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide.
    Vasdev N; LaRonde FJ; Woodgett JR; Garcia A; Rubie EA; Meyer JH; Houle S; Wilson AA
    Bioorg Med Chem; 2008 May; 16(9):5277-84. PubMed ID: 18346896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of potent protein kinase inhibitors using the bisubstrate approach.
    Ricouart A; Gesquiere JC; Tartar A; Sergheraert C
    J Med Chem; 1991 Jan; 34(1):73-8. PubMed ID: 1992155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.
    Collins I; Caldwell J; Fonseca T; Donald A; Bavetsias V; Hunter LJ; Garrett MD; Rowlands MG; Aherne GW; Davies TG; Berdini V; Woodhead SJ; Davis D; Seavers LC; Wyatt PG; Workman P; McDonald E
    Bioorg Med Chem; 2006 Feb; 14(4):1255-73. PubMed ID: 16249095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a conformation-selective casein kinase-1 inhibitor.
    Mashhoon N; DeMaggio AJ; Tereshko V; Bergmeier SC; Egli M; Hoekstra MF; Kuret J
    J Biol Chem; 2000 Jun; 275(26):20052-60. PubMed ID: 10749871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rigidity on the selectivity of protein kinase inhibitors.
    Assadieskandar A; Yu C; Maisonneuve P; Liu X; Chen YC; Prakash GKS; Kurinov I; Sicheri F; Zhang C
    Eur J Med Chem; 2018 Feb; 146():519-528. PubMed ID: 29407977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of cyclic AMP-dependent protein kinase by isoquinoline derivatives.
    Lu ZX; Quazi NH; Deady LW; Polya GM
    Biol Chem Hoppe Seyler; 1996 Jun; 377(6):373-84. PubMed ID: 8839983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity.
    Foloppe N; Fisher LM; Howes R; Kierstan P; Potter A; Robertson AG; Surgenor AE
    J Med Chem; 2005 Jun; 48(13):4332-45. PubMed ID: 15974586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.
    Narayana N; Cox S; Shaltiel S; Taylor SS; Xuong N
    Biochemistry; 1997 Apr; 36(15):4438-48. PubMed ID: 9109651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
    Pingaew R; Prachayasittikul V; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Bioorg Med Chem; 2015 Jul; 23(13):3472-80. PubMed ID: 25934226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugging the Undruggable: How Isoquinolines and PKA Initiated the Era of Designed Protein Kinase Inhibitor Therapeutics.
    Lorenz R; Wu J; Herberg FW; Taylor SS; Engh RA
    Biochemistry; 2021 Nov; 60(46):3470-3484. PubMed ID: 34370450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights.
    Cherry M; Williams DH
    Curr Med Chem; 2004 Mar; 11(6):663-73. PubMed ID: 15032722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly synthesized selective casein kinase I inhibitor, N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide, and affinity purification of casein kinase I from bovine testis.
    Chijiwa T; Hagiwara M; Hidaka H
    J Biol Chem; 1989 Mar; 264(9):4924-7. PubMed ID: 2925675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of heteroaryl substituted diazaspirocycles as scaffolds to probe the ATP-binding site of protein kinases.
    Allen CE; Chow CL; Caldwell JJ; Westwood IM; van Montfort RL; Collins I
    Bioorg Med Chem; 2013 Sep; 21(18):5707-24. PubMed ID: 23920481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of ATP versus GTP selectivity of adenylate kinase.
    Rogne P; Rosselin M; Grundström C; Hedberg C; Sauer UH; Wolf-Watz M
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3012-3017. PubMed ID: 29507216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.
    Tsou HR; Liu X; Birnberg G; Kaplan J; Otteng M; Tran T; Kutterer K; Tang Z; Suayan R; Zask A; Ravi M; Bretz A; Grillo M; McGinnis JP; Rabindran SK; Ayral-Kaloustian S; Mansour TS
    J Med Chem; 2009 Apr; 52(8):2289-310. PubMed ID: 19317452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).
    Asano Y; Kitamura S; Ohra T; Aso K; Igata H; Tamura T; Kawamoto T; Tanaka T; Sogabe S; Matsumoto S; Yamaguchi M; Kimura H; Itoh F
    Bioorg Med Chem; 2008 Apr; 16(8):4715-32. PubMed ID: 18313304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
    Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
    J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.